Non‐Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis

AIMS: Mutant transthyretin (ATTRm) amyloidosis is a systemic disease caused by the deposition of amyloid fibrils derived from mutated transthyretin. Although cardiac involvement impacts the prognosis of patients with ATTRm amyloidosis, the incidence of cardiac events, such as bradyarrhythmia, ventri...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirakawa, Kyoko, Takashio, Seiji, Marume, Kyohei, Yamamoto, Masahiro, Hanatani, Shinsuke, Yamamoto, Eiichiro, Sakamoto, Kenji, Izumiya, Yasuhiro, Kaikita, Koichi, Oda, Seitaro, Utsunomiya, Daisuke, Shiraishi, Shinya, Ueda, Mitsuharu, Yamashita, Taro, Yamashita, Yasuyuki, Ando, Yukio, Tsujita, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352919/
https://www.ncbi.nlm.nih.gov/pubmed/30284755
http://dx.doi.org/10.1002/ehf2.12361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352919/
https://www.ncbi.nlm.nih.gov/pubmed/30284755
http://dx.doi.org/10.1002/ehf2.12361

Ejemplares similares